Recruitment Line : 281-918-0048

NASH, The Silent Liver Killer. Is Your Liver at Risk?

NASH, or Non-Alcoholic Steatohepatitis, is a serious liver condition that could lead to cirrhosis of the liver or even liver cancer. If you are already living with conditions such as obesity and type 2 diabetes, you could be at greater risk! Keep reading to learn if the silent liver killer could be after you.


NAFLD vs. NASH - Is there a difference?


NAFLD, or Non-Alcoholic Fatty Liver Disease, is one of the most common causes of liver disease in the United States. In fact, researchers estimate the numbers could be as high as 40% of all Americans have NAFLD. Simply put, NAFLD is a condition where one has excessive fat buildup around the liver that was not caused by alcohol consumption. With NAFLD, there is typically not scarring of the liver yet and it is rare to show any symptoms, but if left untreated it could progress to NASH.



NASH falls under the NAFLD umbrella, however with this condition, one does have inflammation of the liver. It is estimated that about 20% of those with NAFLD have NASH. So, in all, up to 12% of all Americans could be living with NASH. Again, at this stage, it is rare to have symptoms, but if left untreated, the inflammation in the liver could lead to liver scarring, or cirrhosis, which could lead to liver cancer.






Is Your Liver at Risk?


The typical American diet and lifestyle could be leading to an epidemic! With stats as high 40% of all Americans living with a fatty liver, it seems this condition could affect anyone. Those most at risk for developing NASH are those who are struggling with obesity and other obesity-related conditions such as type 2 diabetes. If NASH progresses as far as fibrosis, cirrhosis, and even liver failure, you could need a liver transplant.




What can you do?



There is currently no FDA approved treatment for NASH, but there are research options. Centex Studies, Inc. is currently conducting the Resolve-IT study for NASH and is seeking volunteers.


To qualify you must:


  • Be a male aged 18-75 years old
  • Be willing and able to undergo a liver biopsy
  • Have a confirmed diagnosis of NASH via the central reading of biopsy
  • Have no other documented cause of chronic liver disease


Access to the investigational medication may be available at no cost, no insurance required and reimbursement for study-related time and travel may be available for those who qualify and participate. Click here to apply and learn more!





Centex Studies, Inc.

Houston 1045 Gemini St. Ste. 200-A

Houston, TX 77058



For Life-Threatening Emergencies

Call 911 or 832-457-2167